Persistent Asset Partners’s Assembly Biosciences ASMB Stock Holding History

Persistent Asset Partners’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$191K	Buy	+6,942	New	+$189K	0.06%	221

Other funds holding ASMB

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Persistent Asset Partners's ASMB Position: Q2 2026 in Review

Persistent Asset Partners opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 6,942 shares worth $191K. The stake represents 0.06% of the portfolio and ranks #221 among its holdings.

15 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

Persistent Asset Partners held 6,942 shares of Assembly Biosciences worth $191K as of Q2 2026.
Assembly Biosciences was a new Persistent Asset Partners position in Q2 2026.
Assembly Biosciences made up 0.06% of Persistent Asset Partners's portfolio in Q2 2026, its #221 holding.
15 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.